- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03641014
Whether Using Sequential pH Would Improve Human Blastocyst Formation
July 14, 2019 updated by: Muhammad Fawzy, Ibn Sina Hospital
Sequential pH Effect on Blastocyst Formation Rate
Any drift in extracellular pH (pHe) from the intercellular pH (pHi) could alter the mechanism regulating transporters and exchangers through the plasma membrane.
This could lead to difficulty in restoring the physiological level of pHi.
The critical stages that lack robust mechanism of regulating the pHi are the denuded oocyte, early stage of fertilization or a thawed embryo.
This, in turn, could lead to a significant effect of the perturbations on embryo development.
Convincing evidence regarding the optimal pHe for culturing human embryo is, so far, scanty and mostly anecdotal.
The embryo has been reported to have a compensatory mechanism to grow at pHe between 7.0-7.4.
Others have recommended that embryo need a sequential pH to viably grow suggesting that the post-genomic activation stage needs a slightly alkaline range of pH.
However, whether this holds true remains to be examined.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1312
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt
- Banon Assiut
-
Quena, Egypt, 12346
- Quena IVF Centre
-
Sohag, Egypt, 12345
- IbnSina IVF Center, IbnSina Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- ICSI cycles
Exclusion Criteria:
- No exclusion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Sequential pH culture (7.23 then 7.35)
A split embryo at day 3 to continue culture at a pHe of 7.23±0.02
or to be cultured at a pH of 7.35±0.02
and monitor the effect on blastocyst development.
|
to investigate which pH is suitable for each stage of embryo development
|
NO_INTERVENTION: Continuously pH culture at 7.23
Embryo culture from day 0 to 5 or 6 at 7.23
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ongoing Pregnancy rate
Time Frame: 12 weeks
|
women with continued pregnancy at week 12 of gestation
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
rate of usable blastocysts
Time Frame: 6 days of culture
|
number of blastocysts suitable for transfer on day 5 or 6
|
6 days of culture
|
Blastocyst formation rate
Time Frame: 6 days of culture
|
number of formed blastocyst per Fertilized oocyte
|
6 days of culture
|
Clinical pregnancy rate
Time Frame: 3 months
|
number of women with ultrasound detection of sacs with heartbeat per stimulated cycle
|
3 months
|
Implantation rate
Time Frame: 7 weeks
|
number of sacs with a heartbeat
|
7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 28, 2018
Primary Completion (ACTUAL)
May 30, 2019
Study Completion (ACTUAL)
June 10, 2019
Study Registration Dates
First Submitted
August 10, 2018
First Submitted That Met QC Criteria
August 20, 2018
First Posted (ACTUAL)
August 21, 2018
Study Record Updates
Last Update Posted (ACTUAL)
July 16, 2019
Last Update Submitted That Met QC Criteria
July 14, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IbnSina-Sequential pH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on pH Effect on blastocyst formation
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptCompleted
-
Ahmad Mustafa Mohamed MetwalleyCompleted
-
Kahramanmaras Sutcu Imam UniversityCompletedDiabetes Mellitus | Diabetic Retinopathy | HormonesTurkey
-
Università degli Studi di SassariUniversity of MilanCompleted
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedCardiopulmonary Arrest With Successful ResuscitationSpain
-
Baskent UniversityCompletedSuture, Complication | IstmocelTurkey
-
Assiut UniversityNot yet recruitingDiabetic PatientsEgypt
-
University of CopenhagenCompletedGlucose Metabolism
-
Assiut UniversityNot yet recruiting
-
University of FloridaRecruitingParkinson Disease | Deep Brain Stimulation | Apraxia, MotorUnited States